Two Massachusetts-based companies, Nanite and Saliogen Therapeutics, are teaming up on a new research project aimed at creating a genetic drug with the potential to treat cystic fibrosis (CF). “Nanite’s relationship with SalioGen is important in the discovery of safe polymeric nanoparticles for a transformative treatment for CF,” said Sean Kevlahan, PhD, CEO and co-founder…
New collective intelligence network to enable cutting-edge oncology research in support of precision medicine BOSTON and ROLES, Switzerland, May 30, 2024 /CNW/ — SOPHIA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced SOPhIA UNITY, a new data-driven consortium, created to accelerate cancer research globally. SOPHIA UNITY…
New collective intelligence network to enable cutting-edge oncology research in support of precision medicine BOSTON and ROLES, Switzerland, May 30, 2024 /PRNewswire/ — SOPhiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced SOPhiA UNITY, a new data-driven consortium, created to accelerate cancer research globally. SOPHIA UNITY…
Graphic abstract. Credit: Cell genomics (2024). DOI: 10.1016/j.xgen.2024.100537 Graduate student Hillary Layden studies transcriptional control in cancer in the lab of Scott Hiebert, the Hortense B. Ingram Chair in Cancer Research and professor of biochemistry. Below, Layden shares results from her research in which she used deep genomic analysis to determine how protein mutations affect…